| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/22/2006 | EP0839185B1 Screening methods for enzymes and enzyme kits |
| 11/22/2006 | EP0825996B1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
| 11/22/2006 | EP0783003B1 G-CSF TPO fusion proteins |
| 11/22/2006 | EP0574461B2 High affinity humanized monoclonal antibodies |
| 11/22/2006 | CN1867677A Process for preparing enantiomer-enriched alpha-hydroxycarboxylic acids and amides |
| 11/22/2006 | CN1867676A Process for producing scyllo-inositol |
| 11/22/2006 | CN1867675A Method of introducing gene into plant material |
| 11/22/2006 | CN1867674A Cloning of cytochrome P450 genes from nicotiana |
| 11/22/2006 | CN1867673A NELL-1 enhanced bone mineralization |
| 11/22/2006 | CN1867672A Improved siRNA molecule and method of inhibiting gene expression with the use of the same |
| 11/22/2006 | CN1867671A Compositions and methods for prognosis and therapy of liver cancer |
| 11/22/2006 | CN1867670A Methods of degrading dsRNA and synthesizing RNA |
| 11/22/2006 | CN1867668A Proteases |
| 11/22/2006 | CN1867588A Product comprising a c4bp core protein and a monomeric antigen, and its use |
| 11/22/2006 | CN1867586A Multispecific deimmunized CD3-binders |
| 11/22/2006 | CN1867362A Cancer gene therapeutic drug |
| 11/22/2006 | CN1867361A Cancer gene therapeutic drug |
| 11/22/2006 | CN1867356A 抗原递送系统 Antigen delivery system |
| 11/22/2006 | CN1865449A 病毒株 Strains |
| 11/22/2006 | CN1865448A Transgenic cow obtaining method |
| 11/22/2006 | CN1865447A High specific activity xylanase expression vector |
| 11/22/2006 | CN1865446A Gene engineered targeted interferon for hepatitis B and its production process |
| 11/22/2006 | CN1865445A scFvC6.5-sTrail fusion gene and protein, and its preparation |
| 11/22/2006 | CN1865444A scFvC6.5-TNF-alpha fusion gene and protein, and its preparation |
| 11/22/2006 | CN1865443A Phosphoenolpyruvate carboxylase gene of watergrass and its coded protein and uses |
| 11/22/2006 | CN1865442A SiRNA sequence aimed at hepatitis B virus gene and its uses |
| 11/22/2006 | CN1865441A Human source nuclein for taking part in microfilament assembly and regulation, and its preparation and application method |
| 11/22/2006 | CN1865440A Novel pathogenetic gene mutation of hypertrophic cardiomyopathy and use thereof |
| 11/22/2006 | CN1865439A Electronic impulse method for transferring gene into turbot using sperm as carrier |
| 11/22/2006 | CN1865431A 1,3-glyceric acid engineered bacteria, its construction and method for producing 1,3-glyceric acid using the said bacteria |
| 11/22/2006 | CN1865430A Engineered bacteria Pichia pastoris for high yield of insulinotropic hormone and its construction method |
| 11/22/2006 | CN1865285A Specific anti-human liver cancer phage single-chain antibody HscFv4-16 gene and its uses |
| 11/22/2006 | CN1865284A Receptor of the edb-fibronectin domains |
| 11/22/2006 | CN1865275A Artificial single-chain deoxynucleotide having therapeutic effect to human B cell tumour |
| 11/22/2006 | CN1864747A Method for preparing active carrier vaccine of avian Chlamydia psittaci |
| 11/22/2006 | CN1285732C Method for preparing polyclonal antibody of human vascular endothelial growth factor |
| 11/22/2006 | CN1285728C Nucleotide to 0-antigen specificity of escherichia coli 0154 type |
| 11/22/2006 | CN1285727C O-antigen specific nucleotide of E.coli 0139 type |
| 11/22/2006 | CN1285726C Nucleotide specific against 0-antigen of shigella dysenteria 3, colibacillus 0124 and 0164 |
| 11/22/2006 | CN1285724C 10-23 desoxyribonuclease of bacillus resisting tubercle branch |
| 11/22/2006 | CN1285722C Peptides natural microbial antiseptic agent producing strain, its use and preparation method for antiseptic agent |
| 11/22/2006 | CN1285721C Gibberella gene engineering bacterium and its preparation and application |
| 11/22/2006 | CN1285613C Antineoplastic rat light chain single domain antibody - Cefuroxime Sodium reinforced fusion protein VL-LDP-AE |
| 11/22/2006 | CN1285612C Animal collagens and gelatins |
| 11/22/2006 | CN1285610C Human liver regeneration promoting factor derivative and its expression |
| 11/22/2006 | CN1285609C Recombinant N protein antigen and purification method for transmissible gastroenteritis of swine |
| 11/22/2006 | CN1285608C Parainfluenza virus glycoproteins and vaccines |
| 11/22/2006 | CN1285606C Nucleotide specific for shigella bodyii 2 O-antigen |
| 11/22/2006 | CN1285381C Chemokine mutants in treatment of multiple sclerosis |
| 11/21/2006 | US7139665 Generating mutant aminoacyl transfer RNA synthetase for de novo design of artificial proteins |
| 11/21/2006 | US7138571 Inbred corn line SE8505 |
| 11/21/2006 | US7138570 Transgenic soybean seeds for propagating disease, insect, heat, drought and herbicide resistant plants |
| 11/21/2006 | US7138569 Nucleic acids encoding pseudomonas hop proteins and use thereof |
| 11/21/2006 | US7138568 Expression vector coding insecticidal protein for use in the transformation and generation of moth resistant leafy plants |
| 11/21/2006 | US7138567 Ga20 oxidase from rice and uses thereof |
| 11/21/2006 | US7138566 Controlling expression of plant growth regulators and producing disease, stress and drought resistant plants |
| 11/21/2006 | US7138565 Methods and means for obtaining modified phenotypes |
| 11/21/2006 | US7138564 Isolated Amaranthus agglutinin gene and uses thereof |
| 11/21/2006 | US7138563 Gene of aluminum-activated malate transporter of a plant and a protein encoded by the gene |
| 11/21/2006 | US7138562 Expression vector for use in generating genetically engineering animal for use as tool in generating preferential proteins |
| 11/21/2006 | US7138517 Sugar modified oligonucleotides |
| 11/21/2006 | US7138515 Translational activity-promoting higher-order structure |
| 11/21/2006 | US7138513 Genes encoding for genetic stability, gene expression and folding proteins |
| 11/21/2006 | US7138512 Gene SHINC-2 and diagnostic and therapeutic uses thereof |
| 11/21/2006 | US7138510 Cloning sequencing and characterization of two cell death genes and uses therefor |
| 11/21/2006 | US7138509 GANP protein |
| 11/21/2006 | US7138508 Inhibitor protein of the wnt signal pathway |
| 11/21/2006 | US7138507 primers for amplification of GST-pi mRNA in fixed and paraffin-embedded (FPE) tumor tissue; use in pharmacogenetics |
| 11/21/2006 | US7138505 of given sequence, for the preparation of human Factor VIIIC, which is absent or defective in individuals with the hereditary bleeding disorder hemophilia A; host cells and expression vectors |
| 11/21/2006 | US7138501 Antibodies that immunospecifically bind BLyS |
| 11/21/2006 | US7138499 antibody that binds to a peptide of given amino acid sequence related to the sulfotransferase drug-metabolizing enzyme subfamily |
| 11/21/2006 | US7138497 Genetic engineering; crosslinking polypeptide on carrier |
| 11/21/2006 | US7138494 Comprises amino acid transport protein (ASC-1) for regulating NMDA-type glutamic acid receptor; treatment of nervous system disorders; antiproliferative agents; gene expression inhibition |
| 11/21/2006 | US7138492 Promoting survival of substantia nigra neuronal cells by contacting with a trophic amount of a ptc therapeutic; mimics hedgehog-mediated patched signal transduction; treating or preventing Parkinson's Disease |
| 11/21/2006 | US7138384 Modulators of DNA cytosine-5 methyltransferase and methods for use thereof |
| 11/21/2006 | US7138383 That retains the high RNA binding affinity of the parent oligonucleotide N3' --> P5' phosphoramidates and exhibits a much higher acid stability; inhibiting human telomerase enzyme activity |
| 11/21/2006 | US7138382 Compositions and methods for drug delivery using pH sensitive molecules |
| 11/21/2006 | US7138381 Compositions containing nucleic acids and ligands for therapeutic treatment |
| 11/21/2006 | US7138380 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease |
| 11/21/2006 | US7138378 Preparing a suppression effector and replacement nucleic acid that have modifications in one or more third base (wobble) positions so that replacement nucleic acids still code for the wild type or equivalent amino acids |
| 11/21/2006 | US7138374 Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, asparate 101 or leucine 137 |
| 11/21/2006 | US7138371 Remodeling and glycoconjugation of peptides |
| 11/21/2006 | US7138370 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents |
| 11/21/2006 | US7138279 Transposases mediated gene transfer of sorangium and polyketide biosynthesis |
| 11/21/2006 | US7138278 Transformation vector which comprises regulatory sequences for expressing trangenes in plants; disease resistant plants |
| 11/21/2006 | US7138277 Genes encoding plant transcription factors |
| 11/21/2006 | US7138276 Differentiation-suppressive polypeptide serrate-2 and methods of use |
| 11/21/2006 | US7138274 Advanced oral poliovirus vaccine (Adv-OPV) deprived of the possibility of vaccine associated paralytic poliomyelities (VAPP) |
| 11/21/2006 | US7138273 Screening for genes which trigger hypersensitive response in tobacco plants in presence of ubiquitous Phytophthora infestans elicitor; horticulture |
| 11/21/2006 | US7138272 Gene transfer in human lymphocytes using retroviral scFv cell targeting |
| 11/21/2006 | US7138267 Methods and compositions for amplifying DNA clone copy number |
| 11/21/2006 | US7138266 Bacterial strain of Escherichia coli BKIIM B-3996 as the producer of L-threonine |
| 11/21/2006 | US7138263 Endoglucanase enzyme NCE5 and cellulase preparations containing the same |
| 11/21/2006 | US7138262 High mannose proteins and methods of making high mannose proteins |
| 11/21/2006 | US7138261 An endoglucanase (especially derived from Zygomycetes) and a reducing agent; treating a cellulose fabric with the cellulase preparation to improve a property; deinking waste paper; improving freeness of paper pulp |
| 11/21/2006 | US7138259 PDEs and uses thereof |
| 11/21/2006 | US7138258 polypeptide that has alpha -2,3-sialyltransferase activity; involved in synthesis of lipooligosaccharides including gangliosides and ganglioside mimics; campylobacter jejuni (C. jejuni) |
| 11/21/2006 | US7138253 Nucleic acid encoding a peptide that binds streptavidin with a dissociation constant less than 10 mu M and that is not disulfide bonded or cyclized; may be expressed as part of fusion proteins to facilitate the detection, quantitation, and purification of proteins of interest. |
| 11/21/2006 | US7138252 For prevention/treatment of allergies/cancer/drug addiction/poisoning |
| 11/21/2006 | US7138251 Polynucleic acid molecule encoding receptors for glial cell line-derived neurotrophic factor |